Cargando…

Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria

BACKGROUND: We aimed to evaluate the effect of immunosuppressant therapy for immunoglobulin A nephropathy (IgAN) patients with mild proteinuria (<1 g/d). METHODS: We recruited patients with biopsy-proven IgAN from 4 study centers. Patients were followed for more than 1 year or up to the study end...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pei, Gaiqin, Tan, Jiaxing, Tang, Yi, Tan, Li, Zhong, Zhengxia, Zhou, Ling, Chen, Changyun, Qin, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	5200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302656/ https://www.ncbi.nlm.nih.gov/pubmed/32541473 http://dx.doi.org/10.1097/MD.0000000000020513

Ejemplares similares

Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021)

Budesonide versus systemic corticosteroids in IgA Nephropathy: A retrospective, propensity-matched comparison
por: Ismail, Gener, et al.
Publicado: (2020)

Corticosteroids Improve Renal Survival: A Retrospective Analysis From Chinese Patients With Early-Stage IgA Nephropathy
por: Qin, Aiya, et al.
Publicado: (2020)

Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
por: Zhai, Ya-Ling, et al.
Publicado: (2016)

Efficacy and safety of immunosuppressive therapies in the treatment of high-risk IgA nephropathy: A network meta-analysis
por: Liu, Tongtong, et al.
Publicado: (2021)

Goodpasture syndrome manifesting as nephrotic-range proteinuria with anti-glomerular basement membrane antibody seronegativity: A case report
por: Zhong, ZhengXia, et al.
Publicado: (2020)

IgA nephropathy pathogenesis and therapy: Review & updates
por: Habas, Elmukhtar, et al.
Publicado: (2022)

Coexisting nutcracker phenomenon and superior mesenteric artery syndrome in a patient with IgA nephropathy: A case report
por: Wang, Chenghua, et al.
Publicado: (2021)

Hypertension/prehypertension and its determinants in pediatric IgA nephropathy
por: Fu, Qing-Ying, et al.
Publicado: (2020)

Pregnancy-induced complications in IgA nephropathy: A case report
por: Chen, Hui, et al.
Publicado: (2018)

Clinical outcomes of IgA nephropathy patients with different proportions of crescents
por: Zhang, Wang, et al.
Publicado: (2017)

Clinicopathological analysis of IgA nephropathy combined with other glomerular diseases
por: Jiang, Lei, et al.
Publicado: (2019)

Pneumocystis pneumonia secondary to intensive immunosuppression treatment for anti-GBM disease complicated with IgA nephropathy: A case report and literature review
por: Zhang, Manyu, et al.
Publicado: (2021)

Differential expression of transfer RNA-derived small RNAs in IgA nephropathy
por: Luo, Zhi-Feng, et al.
Publicado: (2020)

The effect of calcineurin inhibitors in the treatment of IgA nephropathy: A systematic review and meta-analysis (PRISMA)
por: Peng, Wei, et al.
Publicado: (2016)

Nivolumab-induced IgA nephropathy in a patient with advanced gastric cancer: A case report
por: Tanabe, Katsuyuki, et al.
Publicado: (2020)

IgA nephropathy with minimal change disease associated with primary Sjögren’s syndrome: A case report
por: Choi, Jungyoon, et al.
Publicado: (2023)

Weight gain promotes the progression of IgA nephropathy in Asians: A protocol for systematic review and meta-analysis
por: Liu, Meixi, et al.
Publicado: (2022)

Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling
por: Tan, Jiaxing, et al.
Publicado: (2022)

Association of Megsin Gene Variants With IgA Nephropathy in Northwest Chinese Population: A STROBE-Compliant Observational Study
por: Wei, Lin-Ting, et al.
Publicado: (2016)

Identification of key miRNAs and their targets in peripheral blood mononuclear cells of IgA nephropathy using bioinformatics analysis
por: Liu, Ling, et al.
Publicado: (2021)

Clinical characterization of polycythemia vera associated with IgA nephropathy in a single Chinese center: A case series
por: Wang, Xia, et al.
Publicado: (2022)

Cigarette smoking may accelerate the progression of IgA nephropathy
por: Wang, Siqing, et al.
Publicado: (2021)

A multicenter, prospective, observational study to determine association of mesangial C1q deposition with renal outcomes in IgA nephropathy
por: Tan, Li, et al.
Publicado: (2021)

Serum Bilirubin Is Correlated With the Progression of IgA Vasculitis With Nephritis
por: Tan, Jiaxing, et al.
Publicado: (2021)

Galactose-deficient IgA1 and nephritis-associated plasmin receptors as markers for IgA-dominant infection-related glomerulonephritis: A case report
por: Han, Wei, et al.
Publicado: (2021)

High-frequency plasma exchange therapy for immunocompromised, type I crescentic glomerulonephritis complicated with IgA nephropathy: A case report and literature review
por: Chen, Huihui, et al.
Publicado: (2023)

The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis
por: Tan, Jiaxing, et al.
Publicado: (2020)

Effectiveness comparisons of traditional Chinese medicine on treating diabetic nephropathy proteinuria: A systematic review and meta-analysis
por: Wang, Lin, et al.
Publicado: (2019)

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy
por: Sarcina, Cristina, et al.
Publicado: (2016)

Determination of the optimal target level of proteinuria in the management of patients with glomerular diseases by using different definitions of proteinuria
por: Kee, Youn Kyung, et al.
Publicado: (2017)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Coexistence of Fabry disease with IgM nephropathy: A case report
por: Wu, Huizhen, et al.
Publicado: (2019)

Global Glomerulosclerosis and Segmental Glomerulosclerosis Could Serve as Effective Markers for Prognosis and Treatment of IgA Vasculitis With Nephritis
por: Tan, Jiaxing, et al.
Publicado: (2020)

Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study
por: Yang, Ya-zi, et al.
Publicado: (2019)

Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function
por: Tan, Min, et al.
Publicado: (2019)

Efficacy and safety of tacrolimus monotherapy versus tacrolimus-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021)

Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide–corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021)

High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy
por: Wang, Siqing, et al.
Publicado: (2021)

Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria
por: Ruan, Yiping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b34idan1q0fnrfk69g1a8uiopu